PARTNERS
About us
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
Disclaimer: This activity is wholly funded by AstraZeneca. AstraZeneca is involved in and responsible for the development of content related to this activity.
Life without limits, BioPharmaceuticals Ambition in COPD
By investigating a broader range of novel targets, moving from treating symptoms towards disease modification and changing how we run our clinical trials, we are transforming the future of chronic obstructive pulmonary disease (COPD) treatment.
Contact us about Partnership Opportunities
For more information on partnership opportunities at other FT Live events, get in touch today to see how you can get involved.
Z4-39027 | October 2021
© Financial Times Live
FT Live and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice